From pricing scandals to political battles, conversation around the pharmaceutical industry has resulted in the loss
of confidence from investors and HCP’s alike.
Best Pharma Brands (BPB) is a data-driven global study that sets the stage for deeper and more meaningful conversations
between companies, their investors and customers. It puts a stake in the ground for the importance of a company’s
corporate brand and encourages companies to re-think how they share their true value with the marketplace.
The study inspired new ways of looking at the industry, and motivated CEOs and leaders of the most important
pharmaceutical companies to commit to change.